Cerence Inc SEC Filings

Jennifer Salinas, EVP Chief Admin Officer of Cerence Inc. (CRNC), reported two sales of company common stock. On 10/06/2025 she sold 64,784 shares at $12.7573 to satisfy tax withholding required by the company’s RSU sell-to-cover policy. The following day, on 10/07/2025, she sold 77,994 shares at $12.3122 under a pre-established Rule 10b5-1 trading plan adopted on 02/11/2025. After the transactions her reported direct beneficial ownership is 346,289 shares. The filings include a signature dated 10/07/2025 and state the sales were procedural (tax withholding and an existing trading plan) rather than discretionary trades.

Cerence Inc. (CRNC) insider transactions show routine equity activity by CFO Antonio Rodriquez. On 08/15/2025 he purchased 1,795 shares through the companys Employee Stock Purchase Plan at $10.06, bringing his holding to 315,078 shares. On 10/06/2025 he sold 38,347 shares at $12.7573, reducing the stake to 276,731 shares; the sale is identified as a mandatory "sell-to-cover" to satisfy tax-withholding for vested RSUs and not a discretionary trade. The Form 4 is filed jointly by one reporting person and is signed by an attorney-in-fact.

Cerence Inc. (CRNC) reported an insider transaction by EVP and Chief Revenue Officer Christian Mentz showing a mandatory sale of 26,872 shares on 10/06/2025 at a reported price of $12.7573 per share to satisfy tax-withholding on vested restricted stock units (RSUs). After the transaction the reporting person beneficially owned 111,875 shares, reported as disposed for Form 4 purposes. The Form 4 clarifies this was a company‑mandated "sell to cover" to cover tax obligations and is described as not a discretionary trade by the reporting person. The filing was signed by an attorney-in-fact on 10/07/2025.

Cerence Inc. (CRNC) reported a non‑discretionary sale by EVP Product & Technology Nils Schanz on 10/06/2025. The filing shows 30,560 shares were sold at a price of $12.7573 per share to satisfy tax withholding for vested restricted stock units; the company elected a "sell‑to‑cover" method. After the transaction, the reporting person beneficially owns 204,981 shares. The filing is a routine Section 16 disclosure documenting an issuer‑mandated tax withholding sale rather than a voluntary trade.

Cerence Inc. (CRNC) reported a Form 144 notice showing a proposed sale of 77,994 common shares valued at $960,269.93, with an approximate sale date of 10/07/2025 on NASDAQ. The filing shows those shares were acquired as restricted stock from the issuer on 10/01/2025 and paid for on that date. The filing also discloses a recent sale by Jennifer Salinas of 64,784 common shares on 10/06/2025 for gross proceeds of $826,468.92. The notice includes the required attestation that the seller does not possess undisclosed material adverse information and follows Rule 144 procedures for proposed insider sales.

Cerence Inc. (CRNC) reported an insider grant on a Form 4 showing 90,252 restricted stock units granted to Nils Schanz, Executive Vice President, Product & Technology, on 10/01/2025. The units were issued at a nominal price of $0.01 per share and increased his beneficial ownership to 235,541 shares following the grant. The RSUs vest in three equal installments with one-third vesting on each of 10/01/2026, 10/01/2027, and 10/01/2028. The filing is signed by an attorney-in-fact on 10/03/2025.

Cerence Inc. insider sale reported. Christian Mentz, EVP and Chief Revenue Officer, sold 4,000 shares of Cerence common stock on 08/14/2025 at a reported price of $12.7358 per share. After the sale, Mr. Mentz beneficially owned 138,747 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jennifer Salinas, on 08/18/2025 and states the transaction represents shares sold by the reporting person.

Cerence Inc. (CRNC) filed a Form 144 notice reporting a proposed sale of 4,000 shares of common stock, with an aggregate market value of $50,943.20. The shares are part of an issuance recorded as restricted stock acquired from the issuer on 10/01/2024 and were paid in full on that date. The filing names Morgan Stanley Smith Barney LLC as the broker and lists an approximate sale date of 08/14/2025 on the NASDAQ. Total shares outstanding are reported as 43,319,651. The filer affirms they do not possess undisclosed material adverse information about the issuer.